LOC728400 Activators comprise a spectrum of chemical compounds that exert their effects through various intracellular signaling pathways, thereby enhancing the functional activity of LOC728400. Forskolin, by raising intracellular cAMP levels, indirectly augments LOC728400's activity through PKA-mediated phosphorylation events that are critical for LOC728400-associated signaling. Phorbol 12-myristate 13-acetate (PMA) and Ionomycin both influence protein kinase C and calcium-dependent pathways, respectively, which may enhance the functionality of LOC728400 in processes that involve these signaling molecules. Epigallocatechin gallate (EGCG) and Staurosporine, by modulating kinase activity, could shift the balance of phosphorylation in favor of LOC728400's activity, particularly if LOC728400 is subject to regulation by these kinases. Furthermore, Sphingosine-1-phosphate (S1P) engages sphingosine-1-phosphate receptors, potentially leading to downstream signaling effects that enhance LOC728400's role in related pathways.
In addition to the above mechanisms, LOC728400's activity can be influenced by alterations in the PI3K/Akt, MAPK, and calcium signaling pathways. LY294002, a PI3K inhibitor, and U0126 and SB203580, whichtarget MEK1/2 and p38 MAPK respectively, may enhance LOC728400 activity by modulating these pathways, assuming LOC728400 is functionally intertwined with them. The calcium ionophores A23187 and Ionomycin elevate intracellular calcium levels, which could enhance LOC728400's activity if it participates in calcium-dependent signaling mechanisms. Zaprinast, by inhibiting phosphodiesterases and thus increasing cAMP levels, could also indirectly enhance the functional activity of LOC728400, provided that LOC728400 operates within cAMP-dependent pathways. Lastly, Anisomycin, through its role in activating stress-activated protein kinases, may enhance the activity of LOC728400 if it is implicated in the stress response pathways. Collectively, these compounds, by targeting distinct signaling molecules and pathways, serve to enhance the functional activity of LOC728400 without the need for direct agonism or changes in its expression levels.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analogue that activates protein kinase C (PKC). PKC activation may lead to phosphorylation events that enhance the activity of LOC728400 as part of signal transduction processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, thereby activating calcium-dependent proteins and pathways that could enhance the functionality of LOC728400 in calcium signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a polyphenol found in green tea, is known to inhibit certain protein kinases. By inhibiting competitive kinases, EGCG could lead to a relative increase in the activity of LOC728400 by reducing phosphorylation-based inactivation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, involved in intracellular signaling. S1P receptor activation could lead to downstream effects that enhance the activity of LOC728400 in related signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/Akt pathway, potentially enhancing the activity of LOC728400 by affecting downstream signaling mechanisms where LOC728400 plays a role. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which may lead to altered MAPK pathway signaling. This shift in signaling dynamics could potentially enhance the activity of LOC728400 if it is involved in MAPK pathway-related processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could indirectly enhance the activity of LOC728400 by modulating the p38 MAPK signaling pathway, assuming LOC728400 is functionally linked to this pathway. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, potentially enhancing the functional activity of LOC728400 if it is involved in calcium-dependent signaling pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a phosphodiesterase inhibitor, which can increase cAMP levels, potentially leading to enhanced activity of LOC728400 through cAMP-dependent pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. By inhibiting certain kinases, it can potentially lift inhibition on LOC728400, thereby enhancing its activity if LOC728400 is regulated by these kinases. | ||||||